Zydus Lifesciences gets USFDA Approval for Generic Medication

Zydus Lifesciences on Monday said it has received approval from the US health regulator to market a generic medication that is used to lower triglycerides, in the American market.The company has got the final approval from the US Food and Drug A...

Parexel Assigns Scott Smith As New Head Of Haematology

Scott Smith, M.D., Ph.D. has been named senior vice president, global therapeutic area head - haematology at Parexel, one of the world's largest CROs providing a full range of phase I to IV clinical development services. Dr. Smith will be ...

Aptitude Gets $54 million Partnership With BARDA To Develop Diagnostics For Point-Of-Care And At-Home Use

Aptitude Medical Systems (Aptitude) announced a $53.7 million award from the Biomedical Advanced Research and Development Authority (BARDA), which is part of the Administration for Strategic Preparedness and Response within the US Department...

The Rise of Digital Therapeutics in Healthcare

We are rapidly transitioning into an era where software platforms will be treating millions of patients, - thanks to the huge advancements in digital health innovation

Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share

The three-day initial public offering (IPO) will be offered for subscription on April 25-27, with bidding for anchor investors beginning on April 24. Mankind Pharma's initial public offering is scheduled to begin trading next week, with a price...

How AI is revolutionizing drug discovery

Artificial Intelligence (AI) is transforming the healthcare industry in many ways, and drug discovery is no exception. AI has the potential to revolutionize drug discovery by increasing the efficiency and accuracy of the process.

Hasten Biopharmaceutic's $315 million Funding Round Co-led By CBC, Mubadala

China's pharmaceutical firm Hasten Biopharmaceutic has raised $315 million in a fundraising round co-led by Asia's largest healthcare investment firm CBC Group and Abu Dhabi sovereign wealth fund Mubadala Investment Company....

Moderna, IBM Collaborate To Explore Quantum Computing & Generative AI For mRNA Science

Moderna, Inc., a biotechnology company that pioneered messenger RNA (mRNA) therapeutics and vaccines, and IBM announced a collaboration in which Moderna will investigate next-generation technologies such as quantum computing and artificial....

WHO Releases Three Online Products To Support Implementation Of NTD Programmes

The World Health Organisation (WHO) has released three online resources to help countries improve the execution of NTD programmes: an interactive dashboard, an online training course, and a mobile application. The World Health Organisation (WHO)...

US CDC Approves Second Omicron-Updated COVID Booster For Adults

US CDC Approves Second Omicron-Updated COVID Booster For Adults. The agency's decision follows the FDA's approval on Tuesday of a second dose of Omicron-updated booster for the specified high-risk population.

© 2025 India Pharma Outlook. All Rights Reserved.